Lipella Pharmaceuticals I... (LIPO)
undefined
undefined%
At close: undefined

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -4.62M -2.60M -1.87M -61.66K -61.85K
Depreciation & Amortization 1.69K - - - -
Stock-Based Compensation 1.36M 747.40K 728.80K 57.71K -
Other Working Capital 237.23K -327.93K 175.25K -7.48K 24.68K
Other Non-Cash Items 121.20K 9.61K -50.21K 7.64K 18.73K
Deferred Income Tax - - - - -
Change in Working Capital -9.11K 9.52K 197.61K -32.28K 14.34K
Operating Cash Flow -3.15M -1.83M -989.27K -28.58K -39.12K
Capital Expenditures -14.43K - - - -
Acquisitions - - - - -
Purchase of Investments - 300.55M -300.55K - -
Sales Maturities Of Investments - 300.55K - - -
Other Investing Acitivies - -300.55M -300.55K - -
Investing Cash Flow -14.43K 300.55K -300.55K - -
Debt Repayment -275.00K 275.00K - 57.04K 25.00K
Common Stock Repurchased - - - - -
Dividend Paid - - - - -
Other Financial Acitivies 1.61M - - - -
Financial Cash Flow 1.34M 5.24M 2.10M 609.31K 25.00K
Net Cash Flow -1.83M 3.71M 807.09K 580.73K -14.12K
Free Cash Flow -3.16M -1.83M -989.27K -28.58K -39.12K